首页> 外文OA文献 >Suppressive Activity of Vitamin D3 on Matrix Metalloproteinase Production From Cholesteatoma Keratinocytes In Vitro
【2h】

Suppressive Activity of Vitamin D3 on Matrix Metalloproteinase Production From Cholesteatoma Keratinocytes In Vitro

机译:维生素D3对基质的抑制活性 胆脂瘤中金属蛋白酶的产生 角质形成细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is much evidence that degradation of theextracellular matrix is essential for the development ofcholesteatomas and that this is induced by activation of matrixmetalloproteinases (MMPs). Vitamin D3 (VD3) has severalwell-recognised biological activities, including suppression of MMPproduction. The present study, therefore, was undertaken to examinewhether VD3 could suppress MMP production from cholesteatomakeratinocytes in vitro. Keratinocytes (2.5 × 105 cells/mL) induced from cholesteatoma tissue specimenswere cultured with various concentrations of VD3. After one hour,lipopolysaccharide was added to the cell cultures at 100 μg/mL. The culture supernatants were then collected andassayed for MMP-1 and MMP-3 by ELISA. We also used ELISA to measurethe levels of both TIMP (tissue inhibitor of metalloproteinase)-1and TIMP-2 in culture supernatants. Addition of VD3 intokeratinocyte cultures caused the suppression of MMP and TIMPproduction, which was increased by LPS stimulation. This wasdose-dependent. The present results showing the suppressiveactivity of VD3 on the production of MMPs, which are responsible fortissue remodeling, strongly suggest that VD3 would be a goodcandidate for an agent in the medical treatment of, or prophylaxisfor, cholesteatomas.
机译:有许多证据表明,细胞外基质的降解对于胆脂瘤的发生是必不可少的,并且这是由基质金属蛋白酶(MMPs)的激活诱导的。维生素D3(VD3)具有多种公认的生物学活性,包括抑制MMP的产生。因此,本研究旨在检查VD3是否能在体外抑制胆甾醇生成细胞的MMP生成。用各种浓度的VD3培养胆脂瘤组织标本诱导的角质形成细胞(2.5×105 cells / mL)。一小时后,将脂多糖以100μg/ mL加入细胞培养物中。然后收集培养物上清液,并通过ELISA测定MMP-1和MMP-3。我们还使用ELISA来测量培养上清液中TIMP(金属蛋白酶组织抑制剂)-1和TIMP-2的水平。 VD3角质形成细胞培养物的添加导致MMP和TIMP产生的抑制,这通过LPS刺激而增加。这是剂量依赖性的。目前的结果表明,VD3对负责组织重构的MMPs的抑制活性强烈表明,VD3将是胆脂瘤的医学治疗或预防的良好候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号